Cardinal Health Among 9 Companies To Announce Dividend Increases In The First Half Of May

Apple increased its share repurchase authorization by $100 billion and raised its dividend 4%, reinforcing a capital-return-focused allocation. Cardinal Health is expected to announce only a 1-3% dividend increase in early May despite 9% EPS growth in 2025 and 23-25% projected EPS growth for 2026, indicating management continues to favor buybacks over dividend growth. The article is largely a commentary on payout policy rather than a major operational update.

Analysis

The key read-through is not the size of the capital return change, but the signal hierarchy: both companies are telling investors that buybacks are the preferred marginal use of cash, which tends to support per-share math more than headline payout optics. For AAPL, that reinforces a low-volatility earnings-per-share compounding machine, but it also makes the stock more sensitive to the market’s implied repurchase cadence; if operating cash flow stalls even modestly, the valuation can de-rate quickly because the buyback bridge becomes less credible.

For CAH, the disconnect between earnings growth and dividend growth is a subtle but important tell that management sees better risk-adjusted value in retiring stock than in locking in a faster fixed payout. That is constructive for long-term per-share value, but it can cap enthusiasm among income-oriented holders and keep the name in the “cheap but not re-rated” bucket. The second-order effect is that peers with more balanced capital return policies may screen better in dividend-factor portfolios even if CAH’s underlying fundamentals are stronger.

The contrarian angle is that low dividend growth is not necessarily shareholder-unfriendly in the current regime; it may simply reflect disciplined capital allocation while markets overpay for incremental yield. If repurchases remain active, the more important catalyst is not the dividend announcement itself but whether management commentary implies an acceleration or deceleration in buyback pace over the next 2-3 quarters. The main risk is that investors mistake a token dividend raise for stagnation, when in reality the per-share economics could still be improving faster than the market recognizes.

Key Decisions for Investors

• Stay long AAPL into the announcement cycle, but size it as a cash-return compounder rather than a dividend story; target a 3-6 month horizon and watch for any language implying slower repurchase cadence as the main downside risk.
• For CAH, avoid chasing the expected dividend headline; instead, use any post-announcement softness to accumulate on weakness if the buyback authorization/repurchase execution remains robust, with a 2-4 quarter time horizon.
• Pair trade idea: long CAH / short a higher-yield, slower-growth healthcare distributor or defensive dividend proxy over the next 3-6 months, betting the market eventually rewards faster EPS compounding over higher payout optics.
• If AAPL trades up into the event on dividend enthusiasm, consider selling upside calls against a core long position; the risk/reward favors monetizing event-driven premium while retaining exposure to buyback-supported EPS growth.
• Watch for any capital allocation guidance in the next earnings calls: a meaningful step-up in repurchase intensity would be a catalyst for multiple expansion, while any moderation would be the primary thesis break for both names.